Pay in 4 interest-free payments of $6.79 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Berberine metabolites, particularly berberrubine and palmatine, have been shown to significantly increase GLP-1 production in cell studies
CJC-1295 comes in two forms: with DAC (long-acting, 8-day half-life) and without DAC (short-acting, also called Modified GRF 1-29)
Its dual-agonist mechanism provides a competitive edge over the current market leader, semaglutide
Glucagon-like peptide-1 receptor (GLP-1R) is one of the most successful drug targets of T2DM and obesity, and its peptidic ligands have been proposed as potential therapeutic agents for NASH
Biologic-nave obese patients appear to derive the greatest benefit, while those already on IL-17 or IL-23 inhibitors show more modest additive effects, consistent with a predominantly weight-lossmediated mechanism
Dysregulated metabolism in the pathophysiology of non-allergic obese asthma
